Skip to main content

Table 1 Baseline demographics of all study participants

From: Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion

 

All BRVO Patients (n = 29)

Age (range, years)

58.6 ± 13.3 (25 ~ 83)

Gender (%)

 Female

13 (44.8%)

 Male

16 (55.2%)

Diabetes (%)

12 (41.4%)

Hypertension (%)

16 (55.2%)

Eye (%)

 OD

14 (48.3%)

 OS

15 (51.7%)

BCVA, letters (range)

40.9 ± 31.4 (−15 ~ 85)

CRT (range, μm)

457.8 ± 167.1 (229 ~ 787)

IOP (range, mmHg)

15.3 ± 3.3 (8 ~ 21)

Lens Status (%)

 Phakic

21 (72.4%)

 Pseudophakic

8 (27.6%)

Follow-up (range, months)

23.3 ± 15.9 (6 ~ 60)

  1. BCVA best-corrected visual acuity, CRT central retina thickness, IOP intraocular pressure